Sensus Healthcare, Inc. (SRTS)

NASDAQ: SRTS · IEX Real-Time Price · USD
8.96
0.02 (0.22%)
At close: May 27, 2022 4:00 PM
9.28
0.32 (3.57%)
After-hours:May 27, 2022 4:46 PM EDT
Market Cap149.43M
Revenue (ttm)34.31M
Net Income (ttm)21.30M
Shares Out16.68M
EPS (ttm)1.29
PE Ratio6.93
Forward PE5.42
Dividendn/a
Ex-Dividend Daten/a
Volume167,401
Open8.98
Previous Close8.94
Day's Range8.87 - 9.07
52-Week Range3.08 - 11.96
Beta0.52
AnalystsBuy
Price Target14.59 (+62.8%)
Earnings DateMay 5, 2022

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, wh...

IndustryHealth Care Equipment & Supplies
IPO DateJun 3, 2016
CEOJoseph Sardano
Employees37
Stock ExchangeNASDAQ
Ticker SymbolSRTS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is 14.59, which is an increase of 62.83% from the latest price.

Price Target
$14.59
(62.83% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Correction: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective t...

4 days ago - GlobeNewsWire

Why Sensus Healthcare, Inc. (SRTS) Might be Well Poised for a Surge

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

4 days ago - Zacks Investment Research

Wall Street Analysts Think Sensus Healthcare, Inc. (SRTS) Could Surge 53%: Read This Before Placing a Bet

The consensus price target hints at a 52.9% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earn...

1 week ago - Zacks Investment Research

Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective t...

1 week ago - GlobeNewsWire

Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 233.33% and 65.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "...

1 month ago - Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Moves 7.3% Higher: Will This Strength Last?

Sensus Healthcare, Inc. (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...

2 months ago - Zacks Investment Research

8 Micro-Cap Stocks to Buy for a Calculated Gamble

Despite the dismal start to 2022 for the market, micro-cap stocks like eight still offer significant growth potential for investors. The post 8 Micro-Cap Stocks to Buy for a Calculated Gamble appeared f...

2 months ago - InvestorPlace

Here's Why Sensus Healthcare, Inc. (SRTS) Could be Great Choice for a Bottom Fisher

Sensus Healthcare, Inc. (SRTS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions co...

2 months ago - Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Just Overtook the 20-Day Moving Average

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

2 months ago - Zacks Investment Research

Sensus Healthcare to Present at Two Investment Conferences in March

BOCA RATON, Fla. , March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti...

2 months ago - GlobeNewsWire

What Makes Sensus Healthcare, Inc. (SRTS) a Good Fit for "Trend Investing"

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed ...

2 months ago - Zacks Investment Research

Sensus Healthcare Announces Share Repurchase Program

BOCA RATON, Fla, March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective...

2 months ago - GlobeNewsWire

Will Sensus Healthcare, Inc. (SRTS) Gain on Rising Earnings Estimates?

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

2 months ago - Zacks Investment Research

Sensus Healthcare Offloads Sculptura Assets To Focus On Core Dermatology Offerings

Sensus Healthcare Inc (NASDAQ: SRTS) sold its Sculptura assets to Empyrean Medical Systems for $15 million in cash.  The sale included an inventory of Sculptura systems and parts, in addition to all rel...

2 months ago - Benzinga

Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion

2 months ago - GlobeNewsWire

Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "...

3 months ago - Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively

3 months ago - GlobeNewsWire

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Buy These 4 Low-Beta Stocks to Sail Through the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd.

Other symbols:ESEALRN
3 months ago - Zacks Investment Research

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named ...

3 months ago - GlobeNewsWire

Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average

Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?

4 months ago - Zacks Investment Research

Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022

BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non...

4 months ago - GlobeNewsWire

5 Stocks With Recent Price Strength in a Volatile January

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MCB, HBNC, SRTS, OCN and CBZ.

Other symbols:CBZHBNCMCBOCN
4 months ago - Zacks Investment Research